<?xml version='1.0' encoding='utf-8'?>
<response><activities><activity><action_type/><activity_comment/><activity_id>620530</activity_id><activity_properties/><assay_chembl_id>CHEMBL849277</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine induced stereotypy to ED50 for antagonism of apomorphine induced climbing</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1127609</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1994</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL42</molecule_chembl_id><molecule_pref_name>CLOZAPINE</molecule_pref_name><parent_molecule_chembl_id>CHEMBL42</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>155116</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>3.5</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>3.5</value></activity><activity><action_type/><activity_comment/><activity_id>595387</activity_id><activity_properties/><assay_chembl_id>CHEMBL849277</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine induced stereotypy to ED50 for antagonism of apomorphine induced climbing</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>O=c1c2ccccc2cnn1CCCCN1CCN(c2nsc3ccccc23)CC1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1127609</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1994</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL85647</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL85647</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>155112</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>2.5</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>2.5</value></activity><activity><action_type/><activity_comment/><activity_id>1246428</activity_id><activity_properties/><assay_chembl_id>CHEMBL652263</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(-c2ccccc2C(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)nc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL276002</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL276002</parent_molecule_chembl_id><pchembl_value>8.30</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6565</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>5.012</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>8.3</value></activity><activity><action_type/><activity_comment/><activity_id>1210636</activity_id><activity_properties/><assay_chembl_id>CHEMBL881732</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine induced stereotypy to ED50 for antagonism of apomorphine-induced climbing.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>Nc1cccnc1C(=O)NCCCCN1CCN(c2nsc3ccccc23)CC1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1129407</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1996</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL142211</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL142211</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>276895</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>5.0</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>5.0</value></activity><activity><action_type/><activity_comment/><activity_id>624303</activity_id><activity_properties/><assay_chembl_id>CHEMBL849277</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine induced stereotypy to ED50 for antagonism of apomorphine induced climbing</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>O=c1c2ccccc2nnn1CCCCN1CCN(c2nsc3ccccc23)CC1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1127609</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1994</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL314043</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL314043</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>155109</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>3.0</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>3.0</value></activity><activity><action_type/><activity_comment/><activity_id>1188294</activity_id><activity_properties/><assay_chembl_id>CHEMBL849278</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine-induced stereotypy to ED50 for antagonism of apomorphine-induced climbing.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1129407</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1996</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL85</molecule_chembl_id><molecule_pref_name>RISPERIDONE</molecule_pref_name><parent_molecule_chembl_id>CHEMBL85</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>276903</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>4.0</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>4.0</value></activity><activity><action_type/><activity_comment/><activity_id>1257790</activity_id><activity_properties/><assay_chembl_id>CHEMBL652263</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(CCCC)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)nc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL9642</molecule_chembl_id><molecule_pref_name>SC-52892</molecule_pref_name><parent_molecule_chembl_id>CHEMBL9642</parent_molecule_chembl_id><pchembl_value>8.68</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6554</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>2.089</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>8.68</value></activity><activity><action_type/><activity_comment/><activity_id>1227205</activity_id><activity_properties/><assay_chembl_id>CHEMBL652263</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(CCCC)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL9714</molecule_chembl_id><molecule_pref_name>SC-51895</molecule_pref_name><parent_molecule_chembl_id>CHEMBL9714</parent_molecule_chembl_id><pchembl_value>8.65</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6553</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>2.239</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>8.65</value></activity><activity><action_type/><activity_comment/><activity_id>1249206</activity_id><activity_properties/><assay_chembl_id>CHEMBL652263</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(-c2ccccc2)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)nc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL9771</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL9771</parent_molecule_chembl_id><pchembl_value>8.10</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6555</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>7.943</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>8.1</value></activity><activity><action_type/><activity_comment/><activity_id>599271</activity_id><activity_properties/><assay_chembl_id>CHEMBL849277</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine induced stereotypy to ED50 for antagonism of apomorphine induced climbing</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>O=C1Cc2ccccc2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1127609</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1994</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL83454</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL83454</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>155102</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>3.3</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>3.3</value></activity><activity><action_type/><activity_comment/><activity_id>610280</activity_id><activity_properties/><assay_chembl_id>CHEMBL849277</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine induced stereotypy to ED50 for antagonism of apomorphine induced climbing</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>O=C1c2ccccc2CN1CCCCN1CCN(c2nsc3ccccc23)CC1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1127609</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1994</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL41626</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL41626</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>155105</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>3.9</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>3.9</value></activity><activity><action_type/><activity_comment/><activity_id>1201326</activity_id><activity_properties/><assay_chembl_id>CHEMBL881732</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine induced stereotypy to ED50 for antagonism of apomorphine-induced climbing.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>Nc1ccsc1C(=O)NCCCCN1CCN(c2nsc3ccccc23)CC1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1129407</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1996</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL141438</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL141438</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>276891</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>6.0</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>6.0</value></activity><activity><action_type/><activity_comment/><activity_id>1257856</activity_id><activity_properties/><assay_chembl_id>CHEMBL652264</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows Non-competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(-c2ccccc2C(C)(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)nc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL427808</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL427808</parent_molecule_chembl_id><pchembl_value>9.00</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6563</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>1.0</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>9.0</value></activity><activity><action_type/><activity_comment/><activity_id>629438</activity_id><activity_properties/><assay_chembl_id>CHEMBL849277</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine induced stereotypy to ED50 for antagonism of apomorphine induced climbing</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1127609</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1994</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL54</molecule_chembl_id><molecule_pref_name>HALOPERIDOL</molecule_pref_name><parent_molecule_chembl_id>CHEMBL54</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>155115</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>1.8</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>1.8</value></activity><activity><action_type/><activity_comment/><activity_id>1187068</activity_id><activity_properties/><assay_chembl_id>CHEMBL849278</assay_chembl_id><assay_description>Ratio of ED50 for antagonism of apomorphine-induced stereotypy to ED50 for antagonism of apomorphine-induced climbing.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000193</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1129407</document_chembl_id><document_journal>J Med Chem</document_journal><document_year>1996</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL42</molecule_chembl_id><molecule_pref_name>CLOZAPINE</molecule_pref_name><parent_molecule_chembl_id>CHEMBL42</parent_molecule_chembl_id><pchembl_value/><potential_duplicate/><qudt_units/><record_id>276894</record_id><relation>=</relation><src_id>1</src_id><standard_flag/><standard_relation>=</standard_relation><standard_text_value/><standard_type>Ratio</standard_type><standard_units/><standard_upper_value/><standard_value>4.0</standard_value><target_chembl_id>CHEMBL612545</target_chembl_id><target_organism/><target_pref_name>Unchecked</target_pref_name><target_tax_id/><text_value/><toid/><type>Ratio</type><units/><uo_units/><upper_value/><value>4.0</value></activity><activity><action_type/><activity_comment/><activity_id>1256640</activity_id><activity_properties/><assay_chembl_id>CHEMBL652263</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(-c2c(C(C)C)cccc2C(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)nc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL274082</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL274082</parent_molecule_chembl_id><pchembl_value>7.10</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6560</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>79.43</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>7.1</value></activity><activity><action_type/><activity_comment/><activity_id>1261483</activity_id><activity_properties/><assay_chembl_id>CHEMBL652263</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(-c2ccccc2C)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)nc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL276689</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL276689</parent_molecule_chembl_id><pchembl_value>8.70</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6564</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>1.995</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>8.7</value></activity><activity><action_type/><activity_comment/><activity_id>1236088</activity_id><activity_properties/><assay_chembl_id>CHEMBL652264</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows Non-competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(-c2c(C)cccc2C)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)nc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL430152</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL430152</parent_molecule_chembl_id><pchembl_value>9.20</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6562</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>0.631</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>9.2</value></activity><activity><action_type/><activity_comment/><activity_id>1253805</activity_id><activity_properties/><assay_chembl_id>CHEMBL652264</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows Non-competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(-c2ccccc2CC)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)nc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL267809</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL267809</parent_molecule_chembl_id><pchembl_value>8.70</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6566</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>1.995</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>8.7</value></activity><activity><action_type/><activity_comment/><activity_id>1228527</activity_id><activity_properties/><assay_chembl_id>CHEMBL652264</assay_chembl_id><assay_description>Compound was tested for antagonism of Angiotensin II-contracted rabbit aortic rings. Compound shows Non-competitive receptor Antagonism.</assay_description><assay_type>F</assay_type><assay_variant_accession/><assay_variant_mutation/><bao_endpoint>BAO_0000034</bao_endpoint><bao_format>BAO_0000019</bao_format><bao_label>assay format</bao_label><canonical_smiles>CCCCc1cn(-c2c(CC)cccc2CC)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)nc1</canonical_smiles><data_validity_comment/><data_validity_description/><document_chembl_id>CHEMBL1126489</document_chembl_id><document_journal>Bioorg Med Chem Lett</document_journal><document_year>1993</document_year><ligand_efficiency/><modality/><molecule_chembl_id>CHEMBL274668</molecule_chembl_id><molecule_pref_name/><parent_molecule_chembl_id>CHEMBL274668</parent_molecule_chembl_id><pchembl_value>8.70</pchembl_value><potential_duplicate/><qudt_units>http://www.openphacts.org/units/Nanomolar</qudt_units><record_id>6561</record_id><relation>=</relation><src_id>1</src_id><standard_flag>1</standard_flag><standard_relation>=</standard_relation><standard_text_value/><standard_type>Kd</standard_type><standard_units>nM</standard_units><standard_upper_value/><standard_value>1.995</standard_value><target_chembl_id>CHEMBL2094256</target_chembl_id><target_organism>Homo sapiens</target_organism><target_pref_name>Angiotensin II receptor</target_pref_name><target_tax_id>9606</target_tax_id><text_value/><toid/><type>pA2</type><units/><uo_units>UO_0000065</uo_units><upper_value/><value>8.7</value></activity></activities><page_meta><limit>20</limit><next>/chembl/api/data/activity/search?limit=20&amp;offset=20&amp;q=antagonism</next><offset/><previous/><total_count>10000</total_count></page_meta></response>